Document Detail


Dexamethasone inhibition of rat hepatoma growth and alpha-fetoprotein synthesis.
MedLine Citation:
PMID:  6202403     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of dexamethasone on hepatoma growth and differentiation, as well as the production of alpha-fetoprotein (AFP) and albumin, was investigated. Treatment of rats with dexamethasone strongly reduced (by 83 to 98%) the serum levels of AFP in rats bearing Morris hepatomas 7777, 8994, 7288c , and 9618A2 . Reduced AFP levels were due in part to a large reduction in tumor load in dexamethasone-treated rats. Hepatoma weights, on the average, were reduced by 64 to 90% relative to controls, while a large bowel transplantable tumor was affected only slightly. Lower serum AFP levels in rats with hepatomas 7777, 8994, and 9618A2 also resulted from reduced AFP synthesis, as indicated by lower cytoplasmic AFP levels. Cytoplasmic albumin levels were higher in dexamethasone-treated rats bearing hepatomas 7777, 8994, and 7288c than they were in rats which did not receive dexamethasone. RNA dot hybridization also indicated that dexamethasone reduced the amount of AFP mRNA in hepatoma 7777 while increasing albumin mRNA. Two-dimensional gel electrophoresis of tumor cytosol proteins showed that dexamethasone reduced synthesis of all AFP variants which could be detected by this technique. A number of abundant hepatoma-associated and liver-associated proteins were not significantly affected by dexamethasone.
Authors:
D P Huang; C E Schwartz; J F Chiu; J R Cook
Related Documents :
3007703 - Azo dye-induced alterations in vitamin b-6 metabolism and in pyridoxal 5'-phosphate-bin...
2121693 - Neoplastic alteration of a membrane-associated sialidase of rat liver.
6542053 - Comparative pharmacokinetics of trypan blue in female sprague-dawley and long-evans rats.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cancer research     Volume:  44     ISSN:  0008-5472     ISO Abbreviation:  Cancer Res.     Publication Date:  1984 Jul 
Date Detail:
Created Date:  1984-07-20     Completed Date:  1984-07-20     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  2984705R     Medline TA:  Cancer Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2976-80     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Differentiation / drug effects
Cell Division / drug effects
Dexamethasone / toxicity*
Kinetics
Liver Neoplasms, Experimental / physiopathology*
Nucleic Acid Hybridization
Plasmids
RNA, Messenger / genetics
Rats
Serum Albumin / genetics
alpha-Fetoproteins / analysis,  genetics*
Grant Support
ID/Acronym/Agency:
GA 25098//PHS HHS; T32 09286//PHS HHS
Chemical
Reg. No./Substance:
0/RNA, Messenger; 0/Serum Albumin; 0/alpha-Fetoproteins; 50-02-2/Dexamethasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization of an established cell line from human immature teratoma of the ovary and effects o...
Next Document:  Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in viv...